Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon

European Journal of Vascular and Endovascular Surgery Publishes Results Showing Comparable Safety and Efficacy of SurVeil™ DCB Despite IN.PACT™ Admiral™ DCB having 75% Higher Paclitaxel Dose.

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the publication of the TRANSCEND clinical trial, a global randomized study demonstrating the SurVeil™ drug-coated balloon (DCB) is non-inferior to the IN.PACT™ Admiral™ DCB for safety and efficacy in patients with femoropopliteal arterial disease while using a substantially lower drug dose. The findings were published in the March 2025 edition of the European Journal of Vascular and Endovascular Surgery.1

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422628214/en/

Figure 1. SurVeil™ DCB balloon coating (above) vs IN.PACT™ Admiral™ DCB balloon coating (below).

Figure 1. SurVeil™ DCB balloon coating (above) vs IN.PACT™ Admiral™ DCB balloon coating (below).

Surmodics’ leadership in drug-delivery technology dates to the company’s development of the coating used on the first drug-eluding stent (DES), the Johnson & Johnson Cypher™ DES. Surmodics leveraged its rich portfolio of scientific technology to develop the proprietary drug/excipient coating for the SurVeil DCB. This development program aimed to improve drug-delivery performance by enhancing drug retention during delivery to the treatment site, optimizing drug release and retention in the vessel wall, and maximizing drug bioavailability by carefully controlling the microcrystalline morphology of the coating. The uniform microcrystalline coating of the SurVeil DCB is observably different from the coatings of other DCBs (Figure 1). In addition, intense focus was placed on improving coating consistency and durability to minimize distal embolization of coating particulates. The ultimate goal was to produce a coating that minimized the drug dose on the balloon, while maintaining both a profound therapeutic effect and excellent safety profile. The TRANSCEND pivotal trial investigated this goal by comparing the Surmodics SurVeil drug-coated balloon with the market-leading IN.PACT Admiral DCB, which is a high-dose DCB.

Both the SurVeil and IN.PACT Admiral DCBs use coatings with the anti-proliferative drug paclitaxel. The SurVeil DCB has a uniform microcrystalline coating with a 2.0 μg/mm2 drug load and is intended to enhance duration and optimize drug delivery. In contrast, the IN.PACT Admiral has a 75% higher drug load (3.5 μg/mm2) than the SurVeil DCB. The SurVeil DCB, developed and manufactured by Surmodics, is marketed worldwide by Abbott.

Surmodics designed and conducted TRANSCEND, the first global head-to-head study of DCBs. The prospective, multi-center, single-blind, randomized, controlled TRANSCEND study compared the SurVeil DCB and the IN.PACT Admiral DCB for treating superficial femoral and proximal popliteal artery lesions. A total of 446 patients with femoropopliteal artery disease (Rutherford stages 2–4) were randomized to either the SurVeil DCB (n = 222) or the IN.PACT Admiral DCB (n = 224). Patients were enrolled at a total of 65 sites in 9 countries.

The primary efficacy endpoint of 12-month primary patency (freedom from binary restenosis or clinically driven target lesion revascularization) was comparable between the SurVeil DCB and the IN.PACT Admiral DCB (82.2% vs 85.9%). Similarly, the primary safety endpoint, defined as freedom from device or procedure-related death within 30 days and above-ankle amputation or clinically driven target vessel revascularization within 12 months, showed comparable outcomes (91.8% vs 89.9%). Non-inferiority was tested using a multiple imputation approach at one-sided alpha 0.025. Secondary outcomes through 24 months post-procedure were similar between the two groups, further demonstrating the non-inferiority of low-dose SurVeil DCB when compared to IN.PACT Admiral DCB. The company completed collection of 5-year follow-up data in 2024.

“The publication of TRANSCEND demonstrates its high quality of trial design, conduct, and interpretation of results, and establishes a strong evidence base for physician decision-making,” said co-principal investigator Professor Marianne Brodmann, M.D., Head of the Clinical Division of Angiology at the Medical University of Graz, Austria. “Surmodics demonstrated confidence in its technology by choosing to conduct the first worldwide pivotal trial versus a high-dose device. The study’s global patient enrollment lends added confidence to the generalizability of the results.”

In addition to Professor Brodmann, Kenneth Rosenfield, M.D., Section Head for Vascular Medicine and Intervention at Massachusetts General Hospital, Boston; William Gray, M.D., System Chief, Division of Cardiovascular Diseases at Main Line Health, Philadelphia; and Peter Schneider, M.D., Professor of Surgery in the Division of Vascular & Endovascular Surgery at the University of San Francisco, were co-principal investigators of the TRANSCEND study.

“Peripheral artery disease affects more than 100 million people globally, causing chronic pain and disability while severely burdening healthcare systems,” said Dr. Rosenfield. “To meet these challenges, we need PAD treatments with demonstrated long-term safety and effectiveness in maintaining lower limb blood flow. The TRANSCEND study shows that the SurVeil DCB is a best-in-class option for treating femoropopliteal arterial disease that minimizes patient exposure to antiproliferative agents.”

“Surmodics’ decision to execute a Level 1, head-to-head study against the market-leading DCB speaks to our conviction in the company’s scientific know-how and differentiated technology,” said Gary Maharaj, President and Chief Executive Officer of Surmodics. “We are grateful to Professor Brodmann, Drs. Rosenfield, Gray, Schneider, and all the physicians and research coordinators around the world for their commitment to this first-of-its-kind, groundbreaking clinical study. Special thanks go to Dr. Katharina Kurzmann-Gütl, whose exceptional efforts were instrumental to the study’s publication.”

About the SurVeil DCB

The SurVeil DCB, a next-generation device that utilizes best-in-class technology in the treatment of peripheral artery disease (PAD), includes a proprietary drug-excipient formulation for a durable balloon coating and is manufactured using an innovative process to improve coating uniformity. The SurVeil DCB received CE Marking under the EU Medical Device Regulation (EU MDR 2017/745) in December 2023 and received FDA approval in the United States in June 2023.

About Surmodics, Inc.

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface technologies, along with enhanced device design, development, and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements. Statements that are not historical or current facts, including statements regarding the publication of TRANSCEND results establishing a strong evidence base for physician decision-making, and Surmodics’ business strategy, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and important factors could cause actual results to differ materially from those anticipated, including the factors identified under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024, and updated in our subsequent reports filed with the SEC. These reports are available in the Investors section of our website at https://surmodics.gcs-web.com and at the SEC website at www.sec.gov. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them in light of new information or future events.

1. Brodmann M, Gray WA, Schneider PA, et al. Results of SurVeil Versus IN.PACT Admiral Paclitaxel Coated Balloons in Femoropopliteal Arteries: 24 Month Outcomes of the Randomised TRANSCEND Study. Eur J Vasc Endovasc Surg. 2025;69(3):452-462.

Jack Powell, Investor Relations

[email protected]

Surmodics Public Relations Inquiries:

[email protected]

KEYWORDS: United States North America Minnesota

INDUSTRY KEYWORDS: Research Pharmaceutical Oncology Medical Devices Health Technology Clinical Trials Science Surgery Cardiology Medical Supplies FDA Health

MEDIA:

Photo
Photo
Figure 1. SurVeil™ DCB balloon coating (above) vs IN.PACT™ Admiral™ DCB balloon coating (below).
Logo
Logo

Concorde International Group Announces Pricing of $5,000,000 Initial Public Offering

Singapore, April 22, 2025 (GLOBE NEWSWIRE) — Concorde International Group Ltd. (NASDAQ: CIGL) (“Concorde” or the “Company”), an integrated security services provider that combines physical manpower and innovative technology to deliver effective security solutions, today announced the pricing of its initial public offering (the “Offering”) of 1,250,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of US$4.00 per share. The Class A Ordinary Shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on April 22, 2025, under the ticker symbol “CIGL.”

The Company expects to receive aggregate gross proceeds of US$5.0 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45- day option to purchase up to an additional 187,500 Class A Ordinary Shares at the public offering price, less underwriting discounts. The Offering is expected to close on or about April 23, 2025, subject to the satisfaction of customary closing conditions.

The Company intends to use the net proceeds from this Offering for or purchase and rollout of electric vehicular mobile command centers, research and development activities, regional market development and exploration of new markets, product development, working capital and general corporate purposes.

The Offering was conducted on a firm commitment basis. R.F. Lafferty & Co., Inc. (“R.F. Lafferty”) acted as sole book-running manager for the Offering.

A registration statement on Form F-1 (File No. 333-281799) relating to the Offering, as amended, has been filed with the U.S. Securities and Exchange Commission (the “SEC”) and was declared effective by the SEC on March 31, 2025. The Offering was made only by means of a prospectus, forming a part of the registration statement, and a free writing prospectus. Copies of the final prospectus related to the Offering may be obtained from R.F. Lafferty by email at [email protected] or via standard mail to R.F. Lafferty & Co., Inc, 40 Wall Street, 27th Floor, New York, NY10005. In addition, a copy of the final prospectus can also be obtained via the SEC’s website at www.sec.gov.

Before you invest, you should read the prospectus, the free writing prospectus, and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Concorde International Group Ltd

Concorde International Group Limited (Nasdaq: CIGL) is a Singapore-based company specializing in integrated security solutions and facilities management services. Established in 1997, the Company has transitioned from traditional security services to a technology-driven approach. This shift involves deploying advanced systems like CCTV, sensors, and mobile command vehicles, significantly reducing the need for physical guards and enhancing operational efficiency.

For more information, please visit: https://www.concordesecurity.com/

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may, “will, “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, the Company’s statements regarding the expected trading of its Class A Ordinary Shares on the Nasdaq Capital Market and the closing of the Offering. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion of the initial public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, contact:

Investor Relations Contact:

Crescendo Communications, LLC
David Waldman/Natalya Rudman
Tel: (212) 671-1020
Email: [email protected] 



Village Farms International Refinances and Extends Canadian Cannabis Credit Agreement

– Canadian Cannabis Loans consolidated into one facility with a 50 bp rate improvement; extended to February 2028 –

VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced that it has refinanced its syndicated Canadian Cannabis Term Loans, consolidating its three previous loans into one credit facility with two of its existing lenders. The new Canadian cannabis credit facility carries a variable interest rate below 8.0 percent, reflecting a 50 basis point improvement to the previous interest rate, as well as improved financial covenants and a maturity date of February 7, 2028, replacing its previous credit facilities maturing on February 7, 2026.

Michael DeGiglio, Chief Executive Officer of Village Farms commented, “We’re pleased to refinance, consolidate, and extend our Canadian cannabis loan under improved terms. Combined with last week’s announcement about our favorably amended FCC produce loan, we have substantially improved financial flexibility across all areas of our business. These updates demonstrate confidence in our future outlook, driven by continued leadership in our existing markets and a strong platform for growth internationally.”

About Village Farms International

Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods. The Company has a strong foundation as the leading and longest-tenured fresh produce supplier to grocery and large-format retailers throughout the US and Canada and is capitalizing on new high-growth opportunities in the cannabis and CBD categories in North America, the Netherlands and selected markets internationally.

In Canada, the Company’s wholly-owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer and one of Canada’s best-selling brands. The Company also owns 80% of Québec-based, Rose LifeScience, a leading third-party cannabis products commercialization expert in the Province of Québec.

Internationally, Village Farms is targeting selected, nascent, legal cannabis and CBD opportunities with significant medium- and long-term potential. The Company exports medical cannabis from its EU GMP certified facility in Canada to a growing list of international markets including Germany, the United Kingdom, Israel, and Australia. The Company is expanding its international presence with additional export contracts to new countries and customers in the Asia-Pacific and European regions, as well as select strategic investments in operating assets. In Europe, wholly-owned Leli Holland has one of 10 licences to grow and distribute recreational cannabis products.

In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD and hemp-derived brands and e-commerce platforms in the country. Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US high-THC cannabis market via multiple strategies, leveraging one of the largest greenhouse operations in the country (more than 5.5 million square feet in West Texas), as well as the operational and product expertise gained through Pure Sunfarms’ cannabis success in Canada.

Village Farms Clean Energy (VFCE), through a partnership with Atlanta-based Terreva Renewables, creates clean energy from landfill gas at its Delta RNG facility. VFCE receives royalties on all revenue generated. This partnership reduces Vancouver’s greenhouse gas emissions by 475,000 metric tons of CO2 per year, equivalent to removing more than 100,000 vehicles off the road or the energy use equivalent of powering 51,300 homes for one year.

Cautionary Statement Regarding Forward-Looking Information

As used in this Press Release, the terms “Village Farms”, “Village Farms International”, the “Company”, “we”, “us”, “our” and similar references refer to Village Farms International, Inc. and our consolidated subsidiaries, and the term “Common Shares” refers to our common shares, no par value. Our financial information is presented in U.S. dollars and all references in this Press Release to “$” means U.S. dollars and all references to “C$” means Canadian dollars.

This Press Release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is subject to the safe harbor created by those sections. This Press Release also contains “forward-looking information” within the meaning of applicable Canadian securities laws. We refer to such forward-looking statements and forward-looking information collectively as “forward-looking statements”. Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, tariffs, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable or produce industry, the cannabis industry and market and our energy segment are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “can”, “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “try”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this Press Release are subject to risks that may include, but are not limited to: our limited operating history in the cannabis and cannabinoids industry in Leli Holland (“Leli”); the limited operational history of the Delta RNG Project in our energy segment; the legal status of the cannabis business of Pure Sunfarms and Rose, Leli, and the hemp business of Balanced Health and uncertainty regarding the legality and regulatory status of cannabis in the United States; risks relating to the integration of Rose into our consolidated business; risks relating to obtaining additional financing on acceptable terms, including our dependence upon credit facilities and dilutive transactions; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses; our market position and competitive position; our ability to leverage current business relationships for future business involving hemp and cannabinoids; the ability of Pure Sunfarms, Rose and Leli to cultivate and distribute cannabis in their respective regulatory jurisdictions; existing and new governmental regulations, including risks related to regulatory compliance and regarding obtaining and maintaining licenses required under the Cannabis Act (Canada), the Criminal Code and other Acts, S.C. 2018, C. 16 (Canada) for its Canadian operational facilities, the Dutch Closed Coffee Shop Chain Experiment, and changes in our regulatory requirements; risks related to rules and regulations at the U.S. Federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp, cannabidiol-based products commercialization; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; inflationary effects on costs of cultivation and transportation; recessionary effects on demand of our products; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade, including tariffs; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; elevated interest rates; and tax risks.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this Press Release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, which may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including the Company’s most recently filed Quarterly Report on Form 10-Q and the Company’s most recently filed annual report on Form 10-K.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this Press Release relate only to events or information as of the date on which the statements are made in this Press Release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Contact Information

Sam Gibbons
Senior Vice President, Corporate Affairs
Village Farms International
Phone: (407) 936-1190 ext. 328
Email: [email protected]



Laser Photonics and CMS Roll Out Innovative Systems for High-Volume Laser Marking

Laser Photonics and CMS Roll Out Innovative Systems for High-Volume Laser Marking

Revolutionizing Drinkware Customization With Scalable Laser Solutions

ORLANDO, Fla.–(BUSINESS WIRE)–Laser Photonics Corporation (NASDAQ: LASE) (“LPC”), a leading global developer of industrial laser systems for cleaning and other material processing applications, and its subsidiary, Control Micro Systems, Inc. (CMS Laser), announce the launch of their Tumbler Laser Engraving Machines. This technology empowers businesses to accept and process large custom orders in record time, transforming ordinary drinkware into impactful brand statements with personalized text, striking logos, and intricate designs. By enabling high-volume customization with speed and precision, the system helps companies strengthen brand visibility and foster deeper customer engagement.

To supercharge customization workflows for drinkware producers, CMS Laser has unveiled its automated laser marking machine for cylindrical products. These cutting-edge machines leverage the precision of CO2laser marking and CMS Laser’s advanced proprietary software to create permanent impressions on the surface of tumblers.

This non-contact laser ablation technique produces markings without compromising the integrity of the underlying metal. Utilizing the focused energy of light, this method fosters resource efficiency and promotes sustainable practices in industrial marking. Whether it’s a perfectly placed complex corporate emblem, essential product information, or a captivating design wrapping the entire cylinder, the result is consistently exceptional in clarity, contrast, and uniformity.

John Armstrong, the Executive Vice President of LPC, said: “Laser technology, paired with intelligent automation, greatly speeds up product personalization. At Laser Photonics and CMS Laser, we are pioneering a world where every tumbler becomes a canvas for corporate storytelling and expression, delivering an end-to-end solution for cylindrical product manufacturing that is helping etch the future of brand engagement.”

This comprehensive, purpose-built solution seamlessly integrates the core technologies of advanced lasers, precision optics, and intelligent robotics, all orchestrated by integrated machine vision. This synergy guarantees flawless alignment of the marking area and consistently uniform and repeatable results on every single product.

The Tumbler Laser Engraving Machine incorporates a fume extraction process to capture vaporized particles released during the marking process. Whether marking acrylic, enamel, powder coating, or epoxy, these particles are trapped by the filtration system, preventing equipment contamination and ensuring a cleaner, healthier operating environment with minimized maintenance. Beyond the easily replaceable fume extractor filters, minimal consumables are needed, translating to low operating costs and maximized production uptime.

Fueled by CMS Laser’s deep expertise, LPC is strategically investing in cutting-edge research and development for laser marking of tumblers and other cylindrical products. This initiative aligns perfectly with LPC’s broader diversification strategy, aimed at enhancing shareholder value and building resilience in dynamic markets.

To explore the possibilities of CMS Laser’s new Tumbler Laser Engraving Systems or LPC’s comprehensive suite of cleaning, cutting, welding, marking, or engraving laser platforms, visit https://cmslaser.com/ or https://www.laserphotonics.com.

About Laser Photonics Corporation

Laser Photonics is a vertically integrated manufacturer and R&D Center of Excellence for industrial laser technologies and architectures. Laser Photonics seeks to disrupt the $46 billion, centuries-old sand and abrasives blasting markets, focusing on surface cleaning, rust removal, corrosion control, de-painting and other laser-based industrial applications. Laser Photonics’ new generation of leading-edge laser blasting technologies and equipment also addresses the numerous health, safety, environmental and regulatory issues associated with old methods. As a result, Laser Photonics quickly gained a reputation as an industry leader with a brand that stands for quality, technology and product innovation. Currently, world-renowned and Fortune 1000 manufacturers in the aviation, automotive, defense, energy, maritime, nuclear and space industries are using Laser Photonics’ “unique-to-industry” approaches. For more information, visit https://www.laserphotonics.com.

About CMS Laser

Control Micro Systems (CMS Laser), is a 40-year U.S. pioneer in software controls development for laser machines. Today, the company produces turnkey laser material processing systems for marking, cutting, drilling, welding, cleaning and more. Its cutting-edge laser systems are expertly engineered for high-precision applications in a wide range of industries and tailored to each client’s unique manufacturing needs. CMS Laser specializes in developing laser systems for a wide range of industries. It also counts several top 20 global life sciences companies among their customers. For more information, visit Control Micro Systems, Inc., a Laser Photonics company.

Cautionary Note Concerning Forward-Looking Statements

This press release contains “forward-looking statements” (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), including statements regarding the Company’s plans, prospects, potential results and use of proceeds. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption “Risk Factors” in the Registration Statement. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.

Investor Relations and Media Contact:

Brian Siegel, IRC®, M.B.A.

Senior Managing Director

Hayden IR

(346) 396-8696

[email protected]

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS: Supply Chain Management Machinery Hardware Machine Tools, Metalworking & Metallurgy Technology Other Manufacturing Retail Steel Packaging Engineering Other Technology Manufacturing

MEDIA:

Logo
Logo

908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation

908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation

Multiple handheld MX908 devices will be deployed to detect, identify and mitigate illicit drugs like fentanyl, protecting communities amid the opioid crisis

BOSTON–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces a $2M order from the Texas Department of Public Safety for its MX908 handheld mass spectrometry device. This investment in advanced tools for drug detection builds on an initial order placed last year for several MX908 devices, and is funded through the Community Oriented Policing Services (COPS) grant, a federally funded, state-administered program.

The MX908 provides first responders with fast, actionable information when dealing with unknown threats. It detects and identifies trace amounts of hazardous substances, including synthetic opioids such as fentanyl and nitazenes, counterfeit pills and other illicit drugs in various forms.

“Fentanyl is a national crisis, with fentanyl-related deaths in Texas up 158% from 2020 to 2023,” said Kevin J. Knopp, CEO and Co-Founder, 908 Devices. “We’re proud to support the Texas Department of Public Safety at this critical moment, as communities and all levels of government mobilize to confront the rise of illicit drugs like fentanyl to help save lives.”

This order for multiple MX908 devices shipped in April and these devices will be deployed throughout Texas to critical interdiction locations. Agencies including the Criminal Investigations Division and Narcotics Enforcement will benefit from the technology as they continue to modernize frontline detection capabilities in the face of the opioid crisis.

For more information about 908 Devices and the MX908, visit www.908devices.com.

About 908 Devices

908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in vital health and safety applications, such as the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit www.908devices.com.

Forward Looking Statements

This press release includes “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including, without limitation, statements regarding the expected uses and capabilities of the Company’s products. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on management’s current expectations and involve known and unknown risks, uncertainties and assumptions which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement, including the risks outlined under “Risk Factors” and elsewhere in the Company’s filings with the Securities and Exchange Commission which are available on the SEC’s website at www.sec.gov. Additional information will be made available in the Company’s annual and quarterly reports and other filings that it makes from time to time with the SEC. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this press release to reflect changes since the date of this press release, except as may be required by law.

Media Contact

Barbara Russo

[email protected]

Investor Contact

Carrie Mendivil

[email protected]

KEYWORDS: United States North America Texas Massachusetts

INDUSTRY KEYWORDS: Technology Mobile/Wireless Homeland Security Chemicals/Plastics Law Enforcement/Emergency Services Public Policy/Government Manufacturing Hardware State/Local

MEDIA:

Logo
Logo

Solaris completes Warintza drilling campaign and advances key de-risking milestones ahead of major near-term value catalysts

HIGHLIGHTS:

  • Solaris completes significant drilling campaign at its flagship Warintza project

    • 82,000 metres of infill drilling
    • Updated Mineral Resource Estimate targeted for Q3 2025
    • Step-out field exploration activities are ongoing
  • Technical approval of the Environmental Impact Assessment on target for mid-2025

  • Pre-Feasibility Study on target for publication in Q3 2025

  • Re-election of President Daniel Noboa provides political stability, reinforcing the supportive policy environment

QUITO, Ecuador, April 22, 2025 (GLOBE NEWSWIRE) — Solaris Resources Inc. (“Solaris” or the “Company”) (TSX: SLS; NYSE: SLSR) is pleased to announce the completion of a significant drilling campaign at its flagship Warintza Project in southeastern Ecuador, alongside key developments that continue to strategically de-risk and enhance the value of this globally significant copper asset.

Between January 2024 and February 2025, Solaris completed over 82,000 metres of infill drilling, positioning the Company to upgrade a substantial portion of Inferred Resources to the Measured and Indicated categories. An updated Mineral Resource Estimate (MRE), targeted for Q3 2025, will incorporate this data, adding precision and confidence ahead of economic studies and advancing the Warintza Project toward development. The drilling campaign also included more than 15,000 metres of geotechnical, hydrogeological and metallurgical holes that will support the technical studies for the project.

To date, Solaris has drilled over 200,000 metres across the Warintza Central and East porphyry systems. This extensive dataset supports a highly flexible, staged mine plan underpinned by near-surface mineralization, which is expected to materially reduce initial capital requirements. In parallel, improved geological insights have provided an understanding of the highly competitive overburden to ore profiling over the mine life.

As Warintza evolves into a near term, tier-one, multigenerational copper project, Solaris is simultaneously unlocking value across its broader 100%-owned land package of over 260 km², which contains several high-priority regional targets. Step-out field exploration activities are ongoing.

On the infrastructure front, Solaris has now completed 20 kilometres of internal road access, enabling year-round vehicular reach to all project areas. This significantly accelerates the timelines and reduces cost during the construction phase, a key advantage as the Company transitions into development readiness.

The recent re-election of President Daniel Noboa provides political stability, reinforcing the supportive policy environment that has enabled Solaris to maintain progress on permitting and stakeholder engagement. The Company is advancing the technical review of the Environmental Impact Assessment (EIA) in collaboration with Ecuador’s Ministries of Environment and Mines, with approval on target for mid-2025.

In parallel, Solaris is advancing its Pre-Feasibility Study (PFS), led by Ausenco and Knight Piésold, with completion targeted for Q3 2025. Work will then transition into the Bankable Feasibility Study, further underpinning a fully optimized and financeable development plan.

Solaris remains committed to its participatory mining model, fostering strong local partnerships and social license while building long-term value for all stakeholders. With sustained progress across technical, environmental, and social fronts, the Company is on track to deliver a Final Investment Decision (FID) by year-end 2026, a pivotal milestone aligned with a robust global copper market outlook.

Matthew Rowlinson, President and CEO commented, “Ecuador’s future is filled with promise, and we look forward to working hand-in-hand with the new government to unlock the full potential of the Warintza Copper Project, a unique, global-scale, tier 1, multigenerational asset, for Ecuador, by Ecuador.

“Warintza stands as a symbol of what sustainable and responsible development can achieve. Our commitment to operating with integrity, empowering local communities, and creating lasting value for all stakeholders remains at the core of everything we do.

“We are excited for what lies ahead and proud to support Ecuador’s journey toward a bright and prosperous future.”

On behalf of the Board of Solaris Resources Inc.

“Matthew Rowlinson”
President & CEO, Director

For Further Information

Patrick Chambers, VP Investor Relations
Email: [email protected]

About Solaris Resources Inc.

Solaris is a copper-gold exploration and development company, committed to a sustainable future by empowering communities and stakeholders through our dedication to participatory and responsible mining. The Warintza Project, a large copper-gold porphyry deposit, is a unique, global scale and multigenerational asset located in the low capital intensity district of southeast Ecuador. The Company also owns a series of grassroot exploration projects with discovery potential in Peru and Chile and a 60% interest in the La Verde joint-venture project with a subsidiary of Teck Resources in Mexico.  

Cautionary Notes and Forward-looking Statements

This document contains certain forward-looking information and forward
-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of the
words “will” and “
expected” and similar expressions are intended to identify forward-looking statements. These statements include statements regarding the Company’s future growth or value, and expectations regarding the performance and focus of the new management team and Board of Directors; the terms of the private placement; the ability of the Company to satisfy regulatory, stock exchange and commercial closing conditions of the private placement; and the timing, benefits, structure and completion of the proposed emigration. Although Solaris believes that the expectations reflected in such forward-looking statements and/or information are reasonable, readers are cautioned that actual results may vary from the forward-looking statements. The Company has based these forward-looking statements and information on the Company’s current expectations and assumptions about future events including assumptions regarding the exploration and regional programs. These statements also involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements, including the risks, uncertainties and other factors identified in the Solaris Management’s Discussion and Analysis, for the year ended December 31, 2023 available at www.sedarplus.ca. Furthermore, the forward-looking statements contained in this news release are made as at the date of this news release and Solaris does not undertake any obligation to publicly update or revise any of these forward-looking statements except as may be required by applicable securities laws.



Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

ST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 first quarter on Monday, May 12, 2025 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company’s results and corporate developments.

What: Stereotaxis first quarter 2025 financial results conference call
   
When: Monday, May 12, 2025, at 4:30 p.m. ET (1:30 p.m. PT)
   
Dial In Number: To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 4794777.
   
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.
   
Call Replay: A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here.
   


About Stereotaxis


Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.



Investor Contacts:                                        
David L. Fischel                                        
Chairman and Chief Executive Officer                        
                                                        
Kimberly Peery                                                
Chief Financial Officer

314-678-6100
[email protected] 

Valmont Reports First Quarter 2025 Results and Reaffirms 2025 Full-Year Outlook

Valmont Reports First Quarter 2025 Results and Reaffirms 2025 Full-Year Outlook

OMAHA, Neb.–(BUSINESS WIRE)–
Valmont® Industries, Inc. (NYSE: VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today reported financial results for the first quarter ended March 29, 2025.

President and Chief Executive Officer Avner M. Applbaum commented, “Most of our end markets are showing resilience against the current backdrop of economic uncertainty, driving growth in key parts of our business. We’re seeing continued strength in Infrastructure, particularly Utility and Telecommunications, as well as solid demand trends in International Agriculture. Our infrastructure capacity investments are beginning to ramp up and are expected to contribute to sales growth as the year progresses. In Agriculture, strong international performance, especially from large-scale projects, is offsetting softness in the North American market. Our first-quarter results reflect disciplined execution and steady progress on our strategic priorities, which help us remain agile while navigating dynamic conditions, including tariff impacts. Across the organization, we’re executing well and remain confident in our full-year outlook, while also being alert to the rapidly-evolving environment in which we operate, as we deliver value for our customers and shareholders.”

FirstQuarter 2025 Highlights (all metrics compared to First Quarter 2024 unless otherwise noted)

  • Net sales decreased 0.9% to $969.3 million, compared to $977.8 million (increased 0.5% in constant currency1); sales growth in Telecommunications, Utility, and International Agriculture was offset by lower sales in Solar and North America Agriculture
  • Operating income was $128.3 million or 13.2% of net sales, compared to $131.6 million or 13.5% of net sales
  • Diluted earnings per share (“EPS”) of $4.32, same as the prior year
  • Operating cash flows increased to $65.1 million, compared to $23.3 million; cash and cash equivalents were $184.4 million and net leverage ratio was ~1.0x
  • Invested $30.3 million in capital expenditures as the Company invests in future growth
  • Returned $12.0 million to shareholders in dividends and increased the quarterly dividend by 13% to $0.68 per diluted share ($2.72 per diluted share annualized)

Key Financial Metrics

 

 

 

 

 

 

 

 

 

 

First Quarter 2025

 

 

 

(In thousands, except per-share amounts)

 

3/29/2025

 

3/30/2024

 

 

 

 

 

Q1 2025

 

Q1 2024

 

vs. Q1 2024

 

Net Sales

 

$

969,314

 

$

977,828

 

-0.9%

 

Gross Profit

 

 

291,102

 

 

306,216

 

-4.9%

 

Gross Profit as a % of Net Sales

 

 

30.0%

 

 

31.3%

 

 

 

Operating Income

 

 

128,314

 

 

131,553

 

-2.5%

 

Operating Income as a % of Net Sales

 

 

13.2%

 

 

13.5%

 

 

 

Net Earnings Attributable to Valmont Industries, Inc.

 

 

87,261

 

 

87,822

 

-0.6%

 

Diluted Earnings per Share

 

 

4.32

 

 

4.32

 

0.0%

 

Weighted Average Shares Outstanding

 

 

20,196

 

 

20,321

 

 

 

First Quarter 2025 Segment Review (all metrics compared to First Quarter 2024 unless otherwise noted)

Infrastructure(72.6% of Net Sales)

Products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products

Sales decreased 2.4% to $706.2 million, compared to $723.6 million.

Utility sales grew due to higher volumes and pricing actions that more than offset the impact of lower steel prices. Telecommunications sales increased significantly, benefiting from a higher level of carrier spending. Solar sales declined significantly, reflecting lower volumes, partly due to the Company’s strategic decision in the second quarter of 2024 to exit certain low-margin projects. Lower Lighting & Transportation and Coatings sales were primarily driven by softer demand in international markets.

Operating income was $117.2 million or 16.7% of net sales, compared to $117.9 million or 16.4% of net sales.

Agriculture (27.4% of Net Sales)

Center pivot and linear irrigation equipment components for agricultural markets, including aftermarket parts and tubular products, and advanced technology solutions for precision agriculture

Sales increased 3.3% to $267.3 million, compared to $258.7 million.

In North America, irrigation equipment sales were lower due to continued agriculture market softness. Internationally, sales increased significantly, driven by strong growth in the Europe, Middle East, and Africa (“EMEA”) region and higher volumes in Brazil, supported by a stabilizing market environment there.

Operating income decreased 11.6% to $36.2 million or 13.6% of net sales, compared to $41.0 million or 15.9% of net sales. Lower SG&A expense was offset by the impact of volume declines in North America and a higher mix of international projects.

Reaffirming 2025 Full-Year Financial Outlook and Key Assumptions

The Company is reaffirming its full-year 2025 financial outlook, including projected net sales and diluted earnings per share, and updating key assumptions for the year.

   

Metric

2025 Outlook

 

Net Sales

$4.0 to $4.2 billion

 

Infrastructure Net Sales

$3.02 to $3.16 billion

 

Agriculture Net Sales

$0.98 to $1.04 billion

 

Diluted Earnings per Share

$17.20 to $18.80

 

Capital Expenditures

$140 to $160 million

 

Effective Tax Rate

~26.0%

 

 

Key Assumptions, Including Current Tariff Considerations

  • Steel cost assumptions are aligned with futures markets as of April 21, 2025
  • The Company’s fiscal 2025 outlook reflects its current plans and actions underway to mitigate the direct impacts of the following U.S. import tariffs and reciprocal tariffs, as well as retaliatory tariffs from other countries that are in place as of April 18, 2025.

    • 25% Section 232 (steel and aluminum)
    • Section 301 (China – rates vary by good/product)
    • 20% China General
    • 125% China Reciprocal
    • 10% Other Countries Reciprocal, as well as paused reciprocal tariffs
    • 25% Canada Retaliatory (certain imported U.S. goods)
    • 125% China Retaliatory (imported U.S. goods)
    • 25% Mexico and Canada General
  • The Company believes its mitigation plans will enable it to be cost neutral on a dollar basis in fiscal 2025
  • This outlook does not reflect the potential impact of any future revised or additional U.S. tariffs, or future retaliatory measures from other countries

A live audio discussion with Avner M. Applbaum, President and Chief Executive Officer, and Thomas Liguori, Executive Vice President and Chief Financial Officer, will take place on Tuesday, April 22, 2025 at 8:00 a.m. CT. The discussion can be accessed by telephone at +1 877.407.6184 or +1 201.389.0877 (no Conference ID needed) or via webcast at the following link: Valmont Industries 1Q 2025 Earnings Conference Call. A slide presentation will be available for download on the Investors page of valmont.com during the webcast. A replay of the event will be accessible three hours after the call at the above link or by telephone at +1 877.660.6853 or +1 201.612.7415 using access code 13750344. The replay will be available until 10:59 p.m. CT on Tuesday, April 29, 2025.

About Valmont Industries, Inc.

For nearly 80 years, Valmont has been a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity. We are committed to customer-focused innovation that delivers lasting value. Learn more about how we’re Conserving Resources. Improving Life.® at valmont.com.

Concerning Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on assumptions made by management, considering its experience in the industries where Valmont operates, perceptions of historical trends, current conditions, expected future developments, and other relevant factors. It is important to note that these statements are not guarantees of future performance or results. They involve risks, uncertainties (some of which are beyond Valmont’s control), and assumptions. While management believes these forward-looking statements are based on reasonable assumptions, numerous factors could cause actual results to differ materially from those anticipated. These factors include, among other things, risks described in Valmont’s reports to the Securities and Exchange Commission (“SEC”), the Company’s actual cash flows and net income, future economic and market circumstances, industry conditions, company performance and financial results, operational efficiencies, availability and price of raw materials, availability and market acceptance of new products, product pricing, domestic and international competitive environments, geopolitical risks, and actions and policy changes by domestic and foreign governments. The Company cautions that any forward-looking statements in this release are made as of its publication date and does not undertake to update these statements, except as required by law.

Website and Social Media Disclosure

The Company uses its website and social media channels, as identified on its website, to distribute company information. Posts on these channels may contain material information. Therefore, investors should monitor these channels alongside the Company’s press releases, SEC filings, and public conference calls and webcasts. The contents of the Company’s website and social media channels are not considered part of this press release.

1Please see Reg G reconciliation to GAAP measures at end of document

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

(Dollars and shares in thousands, except per-share amounts)

(Unaudited)

 

 

 

 

 

 

 

 

 

Thirteen weeks ended

 

 

March 29,

 

March 30,

 

 

2025

 

2024

Net sales

 

$

969,314

 

 

$

977,828

 

Cost of sales

 

 

678,212

 

 

 

671,612

 

Gross profit

 

 

291,102

 

 

 

306,216

 

Selling, general, and administrative expenses

 

 

162,788

 

 

 

174,663

 

Operating income

 

 

128,314

 

 

 

131,553

 

Other income (expenses):

 

 

 

 

 

 

Interest expense

 

 

(10,115

)

 

 

(16,221

)

Interest income

 

 

3,394

 

 

 

1,779

 

Gain (loss) on deferred compensation investments

 

 

(841

)

 

 

1,431

 

Other

 

 

(2,730

)

 

 

(105

)

Total other income (expenses)

 

 

(10,292

)

 

 

(13,116

)

Earnings before income taxes and equity in loss of nonconsolidated subsidiaries

 

 

118,022

 

 

 

118,437

 

Income tax expense

 

 

30,799

 

 

 

29,988

 

Equity in loss of nonconsolidated subsidiaries

 

 

(560

)

 

 

(20

)

Net earnings

 

 

86,663

 

 

 

88,429

 

Loss (earnings) attributable to redeemable noncontrolling interests

 

 

598

 

 

 

(607

)

Net earnings attributable to Valmont Industries, Inc.

 

$

87,261

 

 

$

87,822

 

 

 

 

 

 

 

 

Weighted average shares outstanding – Basic

 

 

20,047

 

 

 

20,188

 

Earnings per share – Basic

 

$

4.35

 

 

$

4.35

 

 

 

 

 

 

 

 

Weighted average shares outstanding – Diluted

 

 

20,196

 

 

 

20,321

 

Earnings per share – Diluted

 

$

4.32

 

 

$

4.32

 

 

 

 

 

 

 

 

Cash dividends per share

 

$

0.68

 

 

$

0.60

 

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

SUMMARY OPERATING RESULTS

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

Thirteen weeks ended

 

 

March 29,

 

March 30,

 

 

2025

 

2024

Infrastructure

 

 

 

 

 

 

Net sales

 

$

703,491

 

 

$

720,733

 

Gross profit

 

 

212,875

 

 

 

217,617

 

as a percentage of net sales

 

 

30.3

%

 

 

30.2

%

Selling, general, and administrative expenses

 

 

95,663

 

 

 

99,753

 

as a percentage of net sales

 

 

13.6

%

 

 

13.8

%

Operating income

 

 

117,212

 

 

 

117,864

 

as a percentage of net sales

 

 

16.7

%

 

 

16.4

%

 

 

 

 

 

 

 

Agriculture

 

 

 

 

 

 

Net sales

 

$

265,823

 

 

$

257,095

 

Gross profit

 

 

78,227

 

 

 

88,599

 

as a percentage of net sales

 

 

29.4

%

 

 

34.5

%

Selling, general, and administrative expenses

 

 

41,990

 

 

 

47,626

 

as a percentage of net sales

 

 

15.8

%

 

 

18.5

%

Operating income

 

 

36,237

 

 

 

40,973

 

as a percentage of net sales

 

 

13.6

%

 

 

15.9

%

 

 

 

 

 

 

 

Corporate

 

 

 

 

 

 

Selling, general, and administrative expenses

 

$

25,135

 

 

$

27,284

 

Operating loss

 

 

(25,135

)

 

 

(27,284

)

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

SUMMARY OPERATING RESULTS

(Dollars in thousands)

(Unaudited)

 

In the fourth quarter of fiscal 2024, the Company realigned management’s reporting structure for certain composite structure sales and, accordingly, revised its presentation of sales across product lines to reflect how the product is currently managed. The reporting for the thirteen weeks ended March 30, 2024 was adjusted to conform to the realigned presentation. As a result, Utility product line sales increased and Lighting and Transportation product line sales decreased by $10,887 for the thirteen weeks ended March 30, 2024.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Thirteen weeks ended March 29, 2025

 

 

Infrastructure

 

Agriculture

 

Intersegment

 

Consolidated

Geographical Market:

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

$

577,197

 

$

137,476

 

$

(4,112

)

 

$

710,561

International

 

 

129,024

 

 

129,795

 

 

(66

)

 

 

258,753

Total sales

 

$

706,221

 

$

267,271

 

$

(4,178

)

 

$

969,314

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Line:

 

 

 

 

 

 

 

 

 

 

 

 

Utility

 

$

344,265

 

$

 

$

 

 

$

344,265

Lighting and Transportation

 

 

192,571

 

 

 

 

 

 

 

192,571

Coatings

 

 

82,357

 

 

 

 

(2,664

)

 

 

79,693

Telecommunications

 

 

69,939

 

 

 

 

 

 

 

69,939

Solar

 

 

17,089

 

 

 

 

(66

)

 

 

17,023

Irrigation Equipment and Parts

 

 

 

 

242,731

 

 

(1,448

)

 

 

241,283

Technology Products and Services

 

 

 

 

24,540

 

 

 

 

 

24,540

Total sales

 

$

706,221

 

$

267,271

 

$

(4,178

)

 

$

969,314

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Thirteen weeks ended March 30, 2024

 

 

Infrastructure

 

Agriculture

 

Intersegment

 

Consolidated

Geographical Market:

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

$

568,572

 

$

159,915

 

$

(4,466

)

 

$

724,021

International

 

 

155,042

 

 

98,820

 

 

(55

)

 

 

253,807

Total sales

 

$

723,614

 

$

258,735

 

$

(4,521

)

 

$

977,828

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Line:

 

 

 

 

 

 

 

 

 

 

 

 

Utility

 

$

336,143

 

$

 

$

 

 

$

336,143

Lighting and Transportation

 

 

211,209

 

 

 

 

 

 

 

211,209

Coatings

 

 

87,090

 

 

 

 

(2,826

)

 

 

84,264

Telecommunications

 

 

53,961

 

 

 

 

 

 

 

53,961

Solar

 

 

35,211

 

 

 

 

(55

)

 

 

35,156

Irrigation Equipment and Parts

 

 

 

 

233,120

 

 

(1,640

)

 

 

231,480

Technology Products and Services

 

 

 

 

25,615

 

 

 

 

 

25,615

Total sales

 

$

723,614

 

$

258,735

 

$

(4,521

)

 

$

977,828

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

March 29,

 

December 28,

 

 

2025

 

2024

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

184,399

 

$

164,315

Receivables, net

 

 

667,265

 

 

654,360

Inventories

 

 

579,270

 

 

590,263

Contract assets

 

 

197,512

 

 

187,257

Prepaid expenses and other current assets

 

 

94,371

 

 

87,197

Total current assets

 

 

1,722,817

 

 

1,683,392

Property, plant, and equipment, net

 

 

604,118

 

 

588,972

Goodwill and other non-current assets

 

 

1,048,488

 

 

1,057,608

Total assets

 

$

3,375,423

 

$

3,329,972

 

 

 

 

 

 

 

LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Current installments of long-term debt

 

$

669

 

$

692

Notes payable to banks

 

 

51

 

 

1,669

Accounts payable

 

 

348,934

 

 

372,197

Accrued expenses

 

 

223,232

 

 

275,407

Contract liabilities

 

 

140,905

 

 

126,932

Income taxes payable

 

 

33,409

 

 

22,509

Dividends payable

 

 

13,648

 

 

12,019

Total current liabilities

 

 

760,848

 

 

811,425

Long-term debt, excluding current installments

 

 

729,983

 

 

729,941

Operating lease liabilities

 

 

132,083

 

 

134,534

Other non-current liabilities

 

 

60,608

 

 

60,459

Total liabilities

 

 

1,683,522

 

 

1,736,359

Redeemable noncontrolling interests

 

 

56,899

 

 

51,519

Shareholders’ equity

 

 

1,635,002

 

 

1,542,094

Total liabilities, redeemable noncontrolling interests, and shareholders’ equity

 

$

3,375,423

 

$

3,329,972

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

Thirteen weeks ended

 

 

March 29,

 

March 30,

 

 

2025

 

2024

Cash flows from operating activities:

 

 

 

 

 

 

Net earnings

 

$

86,663

 

 

$

88,429

 

Depreciation and amortization

 

 

21,518

 

 

 

23,536

 

Contribution to defined benefit pension plan

 

 

(1,492

)

 

 

(16,714

)

Change in working capital

 

 

(60,468

)

 

 

(88,924

)

Other

 

 

18,909

 

 

 

17,005

 

Net cash flows from operating activities

 

 

65,130

 

 

 

23,332

 

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property, plant, and equipment

 

 

(30,319

)

 

 

(15,010

)

Other

 

 

128

 

 

 

(3,629

)

Net cash flows from investing activities

 

 

(30,191

)

 

 

(18,639

)

Cash flows from financing activities:

 

 

 

 

 

 

Net repayments on short-term borrowings

 

 

(1,601

)

 

 

(1,136

)

Proceeds from long-term borrowings

 

 

60,000

 

 

 

10

 

Principal repayments on long-term borrowings

 

 

(60,174

)

 

 

(175

)

Dividends paid

 

 

(12,019

)

 

 

(12,126

)

Purchases of redeemable noncontrolling interests

 

 

 

 

 

(17,745

)

Other

 

 

(3,199

)

 

 

(3,662

)

Net cash flows from financing activities

 

 

(16,993

)

 

 

(34,834

)

Effect of exchange rates on cash and cash equivalents

 

 

2,138

 

 

 

(3,705

)

Net change in cash and cash equivalents

 

 

20,084

 

 

 

(33,846

)

Cash and cash equivalents—beginning of period

 

 

164,315

 

 

 

203,041

 

Cash and cash equivalents—end of period

 

$

184,399

 

 

$

169,195

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

USE OF NON-GAAP FINANCIAL MEASURES

Management utilizes non-GAAP financial measures to assess the Company’s historical and prospective financial performance, evaluate operational profitability on a consistent basis, factor into executive compensation decisions, and enhance transparency for the investment community. These non-GAAP measures are intended to supplement, not replace, the Company’s reported financial results prepared in accordance with GAAP. It is important to note that other companies may calculate these measures differently, which can limit their usefulness for comparison across organizations.

The following non-GAAP measures may be included in financial releases and other financial communications:

  • Adjusted Operating Income, Adjusted Operating Margin, Adjusted Net Earnings, and Adjusted Diluted EPS: These metrics provide meaningful supplemental insights into the Company’s operating performance by excluding items that are not considered part of core operating results. This approach enhances comparability across reporting periods. Adjustments may include costs or benefits associated with acquisitions, divestitures, expenses related to realignment or restructuring programs, goodwill or intangible asset impairment, significant expenses or benefits from changes in tax laws or rates, cumulative effects of changes in accounting standards, refinancing-related expenses, loss or gain from a partial or full settlement of the U.K. defined benefit pension plan obligation, losses from natural disasters, and other non-recurring items.
  • Adjusted EBITDA: This metric is a key component of a financial ratio included in the covenants of our major debt agreements. It is calculated as net earnings before interest, taxes, depreciation, amortization, stock-based compensation, and other adjustments as outlined in the applicable debt agreements. This metric offers investors and analysts valuable insights into the Company’s core operating performance. Adjusted EBITDA margin is also used to evaluate profitability.
  • Leverage Ratio: This ratio is calculated by taking the sum of interest-bearing debt, minus unrestricted cash in excess of $50.0 million (but not exceeding $500.0 million), and dividing it by Adjusted EBITDA. This is a key financial ratio included in the covenants of our major debt agreements and is calculated on a rolling four-fiscal-quarter basis.
  • Free Cash Flow: Calculated as net cash provided by operating activities minus capital expenditures, free cash flow serves as an indicator of the Company’s financial strength. However, this measure does not fully reflect the Company’s ability to deploy cash freely, as it has obligations such as debt repayments and other fixed commitments.
  • Backlog: This operating measure is used to evaluate future potential sales revenue. An order is included in the backlog upon receipt of a customer purchase order or the execution of a sales order contract. Backlog is particularly relevant to the Infrastructure segment due to the longer-term nature of its projects. However, backlog is not a term defined under U.S. GAAP and does not measure contract profitability. It should not be viewed as the sole indicator of future revenue, as many projects with short lead times book-and-bill within the same reporting period and are not included in the backlog.
  • Constant Currency: Defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
  • ROIC: Return on invested capital (“ROIC”) and adjusted ROIC are key operating ratios that enable investors to assess our operating performance relative to the investment needed to generate operating profit. ROIC is calculated as after-tax operating income divided by the average of beginning and ending invested capital. Adjusted ROIC is calculated as after-tax adjusted operating income divided by the average of beginning and ending invested capital. Invested capital represents total assets minus total liabilities (excluding interest-bearing debt and redeemable noncontrolling interests).

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

REGULATION G RECONCILIATION OF ADJUSTED EBITDA

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

Four fiscal quarters ended

 

 

March 29,

 

 

2025

Net cash flows from operating activities

 

$

614,476

 

Interest expense

 

 

52,616

 

Income tax expense

 

 

118,789

 

Deferred income taxes

 

 

24,560

 

Redeemable noncontrolling interests

 

 

(1,160

)

Net periodic pension cost

 

 

(740

)

Contribution to defined benefit pension plan

 

 

4,377

 

Changes in assets and liabilities

 

 

(157,842

)

Other

 

 

(12,699

)

Proforma divestitures adjustment

 

 

(1,548

)

Adjusted EBITDA

 

$

640,829

 

 

 

 

 

Net earnings attributable to Valmont Industries, Inc.

 

$

347,698

 

Interest expense

 

 

52,616

 

Income tax expense

 

 

118,789

 

Depreciation and amortization

 

 

93,377

 

Stock-based compensation

 

 

29,897

 

Proforma divestitures adjustment

 

 

(1,548

)

Adjusted EBITDA

 

$

640,829

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

REGULATION G RECONCILIATION OF LEVERAGE RATIO

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

March 29,

 

 

 

2025

 

Interest-bearing debt, excluding origination fees and discounts of $25,435

 

$

756,138

 

Less: Cash and cash equivalents in excess of $50,000

 

 

134,399

 

Net indebtedness

 

$

621,739

 

Adjusted EBITDA

 

 

640,829

 

Leverage ratio

 

 

0.97

 

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

BACKLOG

(Dollars in millions)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

March 29,

 

December 28,

 

 

 

2025

 

2024

 

Infrastructure

 

$

1,327.4

 

$

1,273.3

 

Agriculture

 

 

161.8

 

 

163.4

 

Total backlog

 

$

1,489.2

 

$

1,436.7

 

VALMONT INDUSTRIES, INC. AND SUBSIDIARIES

REGULATION G RECONCILIATION OF CONSTANT CURRENCY

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2025 Net Sales Outlook

 

 

Low End

 

High End

 

 

Infrastructure

 

Agriculture

 

Consolidated

 

Infrastructure

 

Agriculture

 

Consolidated

Net sales

 

$

3,025,000

 

 

$

975,000

 

 

$

4,000,000

 

 

$

3,160,000

 

 

$

1,040,000

 

 

$

4,200,000

 

Impact of foreign exchange

 

 

35,000

 

 

 

25,000

 

 

 

60,000

 

 

 

35,000

 

 

 

25,000

 

 

 

60,000

 

Net sales – constant currency

 

$

3,060,000

 

 

$

1,000,000

 

 

$

4,060,000

 

 

$

3,195,000

 

 

$

1,065,000

 

 

$

4,260,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales – year-over-year change

 

 

0.9

%

 

 

(9.4

)%

 

 

(1.8

)%

 

 

5.4

%

 

 

(3.4

)%

 

 

3.1

%

Impact of foreign exchange

 

 

1.2

%

 

 

2.3

%

 

 

1.5

%

 

 

1.2

%

 

 

2.3

%

 

 

1.5

%

Net sales – constant currency

 

 

2.1

%

 

 

(7.1

)%

 

 

(0.4

)%

 

 

6.6

%

 

 

(1.1

)%

 

 

4.5

%

 

The above foreign exchange impact assumes the following currency exchange rates for the most significant translation effects: BRL/USD: 5.90, AUD/USD: 1.58, and EUR/USD: 0.96

 

 

 

 

 

 

 

 

 

 

 

 

Thirteen weeks ended March 29, 2025

 

 

Infrastructure

 

Agriculture

 

Consolidated

Net sales

 

$

703,491

 

 

$

265,823

 

 

$

969,314

 

Impact of foreign exchange

 

 

6,070

 

 

 

7,083

 

 

 

13,153

 

Net sales – constant currency

 

$

709,561

 

 

$

272,906

 

 

$

982,467

 

 

 

 

 

 

 

 

 

 

 

Net sales – year-over-year change

 

 

(2.4

)%

 

 

3.4

%

 

 

(0.9

)%

Impact of foreign exchange

 

 

0.8

%

 

 

2.8

%

 

 

1.3

%

Net sales – constant currency

 

 

(1.6

)%

 

 

6.1

%

 

 

0.5

%

 

Renee Campbell

[email protected]

KEYWORDS: United States North America Nebraska

INDUSTRY KEYWORDS: Technology Agritech Agriculture Natural Resources

MEDIA:

Logo
Logo

HASI Announces First Quarter 2025 Earnings Release Date and Conference Call

HASI Announces First Quarter 2025 Earnings Release Date and Conference Call

ANNAPOLIS, Md.–(BUSINESS WIRE)–
HA Sustainable Infrastructure Capital, Inc. (“HASI,” or the “Company”) (NYSE: HASI), a leading investor in sustainable infrastructure assets, today announced that the Company will release its first quarter 2025 results after market close on Wednesday, May 7, 2025, to be followed by a conference call at 5:00 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-877-407-0890 (Toll-Free) or +1-201-389-0918 (toll). Participants should inform the operator you want to be joined to the “HASI First Quarter 2025 Results” call. The conference call will also be accessible as an audio webcast with slides on our website. A replay after the event will be accessible as on-demand webcast on our website.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investors section of the Company’s website at https://investors.hasi.com/. The online replay will be available for a limited time beginning immediately following the call.

To learn more about HASI, please visit the Company’s website at www.hasi.com. In addition to filing or furnishing required information to the U.S. Securities and Exchange Commission, HASI uses its website as a channel of distribution of material Company information. Financial and other material information regarding HASI is routinely posted on the Company’s website and is readily accessible.

About HASI

HASI is an investor in sustainable infrastructure assets advancing the energy transition. With approximately $14 billion in managed assets, our investments are diversified across multiple asset classes, including utility-scale solar, onshore wind, and storage; distributed solar and storage; RNG; and energy efficiency. We combine deep expertise in energy markets and financial structuring with long-standing programmatic client partnerships to deliver superior risk-adjusted returns and measurable environmental benefits. HA Sustainable Infrastructure Capital, Inc. is listed on the New York Stock Exchange (Ticker: HASI). For more information, please visit hasi.com.

Aaron Chew

[email protected]

410-571-6189

KEYWORDS: United States North America Maryland

INDUSTRY KEYWORDS: Environment Finance Other Energy Environmental Health Utilities Professional Services Sustainability Alternative Energy Energy Asset Management

MEDIA:

Logo
Logo

SolarEdge to Announce Financial Results for the First Quarter Ended March 31, 2025, on Tuesday, May 6, 2025

SolarEdge to Announce Financial Results for the First Quarter Ended March 31, 2025, on Tuesday, May 6, 2025

MILPITAS, Calif.–(BUSINESS WIRE)–SolarEdge Technologies, Inc. (Nasdaq: SEDG), a global leader in smart energy technology, will report financial results for the first quarter ended March 31, 2025, before market open on Tuesday, May 6, 2025. Management will host a conference call at 8:00 A.M. ET on Tuesday, May 6, 2025, to discuss these results.

The call will be available, live, to interested parties by dialing:

United States/Canada Toll Free:

+1 800-579-2543

International Toll:

+1 785-424-1789

Conference ID:

SEDG

To avoid a delay in connecting to the call, please dial into the call 10 minutes prior to the start time. A live webcast will be available in the Investor Relations section of SolarEdge’s website at: Event Calendar | SolarEdge Technologies, Inc.

A replay of the webcast will be available in the Investor Relations section of the company’s web site approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days.

About SolarEdge

SolarEdge is a global leader in smart energy technology. By leveraging world-class engineering capabilities and with a relentless focus on innovation, SolarEdge creates smart energy solutions that power our lives and drive future progress. SolarEdge developed an intelligent inverter solution that changed the way power is harvested and managed in photovoltaic (PV) systems. The SolarEdge DC optimized inverter seeks to maximize power generation while lowering the cost of energy produced by the PV system. Continuing to advance smart energy, SolarEdge addresses a broad range of energy market segments through its PV, storage, EV charging, batteries, and grid services solutions. Visit SolarEdge online at www.solaredge.com.

Investor Contacts

SolarEdge Technologies, Inc.

JB Lowe, Head of Investor Relations

[email protected]

Sapphire Investor Relations, LLC

Erica Mannion and Michael Funari

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Technology Engineering Utilities Manufacturing Alternative Vehicles/Fuels Automotive Batteries Alternative Energy Energy Construction & Property Building Systems Environment Hardware Green Technology

MEDIA: